Colon cancer drug ``boosts survival''
A colon cancer drug has boosted overall survival in heavily pre-treated patients with advanced metastatic colon cancer, it has been claimed.
By focusing on the differences, researchers at Karolinska Institutet have found a new way of tackling colon cancer.